References

Toxic Endothelial Cell Destruction of the Cornea After Routine Extracapsular Cataract Surgery

10.1001/archopht.1990.01070100077038 · ExternalCitation · doi-reference

Psychiatric manifestations of homocystinuria due to cystathionine β-synthase deficiency: Prevalence, natural history, and relationship to neurologic impairment and vitamin B6 -responsiveness

10.1002/ajmg.1320260427 · ExternalCitation · doi-reference

Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance

10.1002/ajmg.a.31932 · ExternalCitation · doi-reference

Clinical Evaluation and Management of Thrombotic Microangiopathy

10.1002/art.42681 · ExternalCitation · doi-reference

cblE Type of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expression

10.1002/humu.20131 · ExternalCitation · doi-reference

Vitamin B 12, folate, and the methionine remethylation cycle—Biochemistry, pathways, and regulation

10.1002/jimd.12009 · ExternalCitation · doi-reference

Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration

10.1002/jps.21079 · ExternalCitation · doi-reference

Pharmaceutical Nanotechnology Nanoparticle-Based Topical Ophthalmic Formulations for Sustained Celecoxib Release

10.1002/jps.23417 · ExternalCitation · doi-reference

Rapid screening of MMACHC gene mutations by high-resolution melting curve analysis

10.1002/mgg3.1221 · ExternalCitation · doi-reference

Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis

10.1002/mgg3.1838 · ExternalCitation · doi-reference

Pulmonary embolism in a child with combined methylmalonic acidemia and homocystinuria

10.1002/ped4.12047 · ExternalCitation · doi-reference

Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes

10.1002/smll.201303433 · ExternalCitation · doi-reference

10.1007/978-1-62703-475-3

10.1007/978-1-62703-475-3 · ExternalCitation · doi-reference

Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration

10.1007/s00417-004-0961-4 · ExternalCitation · doi-reference

Cobalamin C defect presenting as severe neonatal hyperammonemia

10.1007/s00431-010-1371-8 · ExternalCitation · doi-reference

Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder

10.1007/s00467-007-0604-1 · ExternalCitation · doi-reference

Renal thrombotic microangiopathy in patients with cblC defect: Review of an under-recognized entity

10.1007/s00467-016-3399-0 · ExternalCitation · doi-reference

Hemolytic uremic syndrome with dual caution in an infant: Cobalamin C defect and complement dysregulation successfully treated with eculizumab

10.1007/s00467-018-3941-3 · ExternalCitation · doi-reference

Cobalamin C defect: Natural history, pathophysiology, and treatment

10.1007/s10545-010-9161-z · ExternalCitation · doi-reference

Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management

10.1007/s10545-011-9364-y · ExternalCitation · doi-reference

Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency

10.1007/s10545-016-9991-4 · ExternalCitation · doi-reference

Why I Use Subcutaneous Immunoglobulin (SCIG)

10.1007/s10875-012-9853-2 · ExternalCitation · doi-reference

Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs

10.1007/s11095-012-0889-z · ExternalCitation · doi-reference

Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives

10.1007/s13346-020-00843-z · ExternalCitation · doi-reference

A Review on Graphene-Based Nanomaterials in Biomedical Applications and Risks in Environment and Health

10.1007/s40820-018-0206-4 · ExternalCitation · doi-reference

Defective metabolism of vitamin B12 in fibroblasts from children with methylmalonicaciduria

10.1016/0006-291x(71)90610-3 · ExternalCitation · doi-reference

Kinetics of macromolecules injected into the subretinal space

10.1016/0014-4835(85)90138-1 · ExternalCitation · doi-reference

Hyperammonemia

10.1016/0045-9380(84)90047-1 · ExternalCitation · doi-reference

10.1016/b0-12-227055-x/00257-1

10.1016/b0-12-227055-x/00257-1 · ExternalCitation · doi-reference

10.1016/b978-0-12-391909-0.50043-8

10.1016/b978-0-12-391909-0.50043-8 · ExternalCitation · doi-reference

10.1016/b978-0-323-46143-6.00013-0

10.1016/b978-0-323-46143-6.00013-0 · ExternalCitation · doi-reference

10.1016/b978-0-323-91864-0.00007-3

10.1016/b978-0-323-91864-0.00007-3 · ExternalCitation · doi-reference

10.1016/b978-0-443-15264-1.00019-1

10.1016/b978-0-443-15264-1.00019-1 · ExternalCitation · doi-reference

10.1016/b978-012080261-6/50026-x

10.1016/b978-012080261-6/50026-x · ExternalCitation · doi-reference

Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin

10.1016/j.actbio.2015.12.017 · ExternalCitation · doi-reference

Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling

10.1016/j.addr.2006.07.025 · ExternalCitation · doi-reference

Cyclodextrins as pharmaceutical solubilizers

10.1016/j.addr.2007.05.012 · ExternalCitation · doi-reference

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches

10.1016/j.addr.2018.01.008 · ExternalCitation · doi-reference

Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives

10.1016/j.addr.2023.114770 · ExternalCitation · doi-reference

Solid implantable devices for sustained drug delivery

10.1016/j.addr.2023.114950 · ExternalCitation · doi-reference

Microneedles for advanced ocular drug delivery

10.1016/j.addr.2023.115082 · ExternalCitation · doi-reference

A Novel RP1 Truncating mutation That Causes Autosomal Dominant Retinitis Pigmentosa (ADRP)

10.1016/j.aopr.2024.08.005 · ExternalCitation · doi-reference

Vitamin B12 absorption: Mammalian physiology and acquired and inherited disorders

10.1016/j.biochi.2012.11.004 · ExternalCitation · doi-reference

Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration

10.1016/j.biomaterials.2011.10.010 · ExternalCitation · doi-reference

Platelet-derived extracellular vesicle drug delivery system loaded with kaempferol for treating corneal neovascularization

10.1016/j.biomaterials.2025.123205 · ExternalCitation · doi-reference

Noninvasive ocular delivery of adalimumab-loaded nanostructured lipid carriers for targeted retinitis pigmentosa therapy

10.1016/j.biopha.2025.117962 · ExternalCitation · doi-reference

Cyclodextrin-based ocular drug delivery systems: A comprehensive review

10.1016/j.ccr.2022.214919 · ExternalCitation · doi-reference

Killing three birds with one stone: Multi-stage metabolic regulation mediated by clinically usable berberine liposome to overcome photodynamic immunotherapy resistance

10.1016/j.cej.2022.140164 · ExternalCitation · doi-reference

Influence of serial intravitreal injections on measures of dry eye: A systemic review and meta-analysis

10.1016/j.clae.2024.102127 · ExternalCitation · doi-reference

Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis

10.1016/j.colsurfb.2015.03.059 · ExternalCitation · doi-reference

Cubosomes: Remarkable drug delivery potential

10.1016/j.drudis.2016.01.004 · ExternalCitation · doi-reference

Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye—Part II—Ocular drug-loaded lipid nanoparticles

10.1016/j.ejpb.2016.10.013 · ExternalCitation · doi-reference

Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies

10.1016/j.ejpb.2017.01.008 · ExternalCitation · doi-reference

Current trends in pharmaceutical treatment of dry eye disease: A review

10.1016/j.ejps.2022.106206 · ExternalCitation · doi-reference

Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy

10.1016/j.ekir.2018.05.015 · ExternalCitation · doi-reference

Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye

10.1016/j.exer.2015.10.009 · ExternalCitation · doi-reference

Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics

10.1016/j.exer.2019.107829 · ExternalCitation · doi-reference

Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride

10.1016/j.ijbiomac.2018.05.113 · ExternalCitation · doi-reference

Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route

10.1016/j.ijbiomac.2020.02.097 · ExternalCitation · doi-reference

Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate

10.1016/j.ijpharm.2005.05.036 · ExternalCitation · doi-reference

Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct

10.1016/j.ijpharm.2007.12.007 · ExternalCitation · doi-reference

Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study

10.1016/j.ijpharm.2011.03.043 · ExternalCitation · doi-reference

Spanlastics—A novel nanovesicular carrier system for ocular delivery

10.1016/j.ijpharm.2011.04.027 · ExternalCitation · doi-reference

Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits

10.1016/j.ijpharm.2013.11.043 · ExternalCitation · doi-reference

Brinzolamide nanocrystal formulations for ophthalmic delivery: Reduction of elevated intraocular pressure in vivo

10.1016/j.ijpharm.2014.03.048 · ExternalCitation · doi-reference

An optimized gastroretentive nanosystem for the delivery of levodopa

10.1016/j.ijpharm.2015.08.014 · ExternalCitation · doi-reference

Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives

10.1016/j.ijpharm.2016.07.031 · ExternalCitation · doi-reference

Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye

10.1016/j.ijpharm.2017.04.010 · ExternalCitation · doi-reference

Designing lipid nanoparticles for topical ocular drug delivery

10.1016/j.ijpharm.2017.09.017 · ExternalCitation · doi-reference

Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system

10.1016/j.ijpharm.2019.06.022 · ExternalCitation · doi-reference

Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability

10.1016/j.ijpharm.2019.118688 · ExternalCitation · doi-reference

Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma

10.1016/j.ijpharm.2021.120380 · ExternalCitation · doi-reference

A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system

10.1016/j.ijpharm.2022.121878 · ExternalCitation · doi-reference

Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery

10.1016/j.ijpharm.2023.123006 · ExternalCitation · doi-reference

Delivery of Fenofibrate to Ocular Tissues using 2-Hydroxypropyl-β-cyclodextrin-Based Micelles

10.1016/j.ijpharm.2025.125417 · ExternalCitation · doi-reference

Long acting injectables & implants: Advances in intraocular drug delivery

10.1016/j.ijpharm.2025.126058 · ExternalCitation · doi-reference

Enhanced corneal permeation of diclofenac through an ophthalmic nanocrystal suspension

10.1016/j.ijpharm.2025.126272 · ExternalCitation · doi-reference

Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C disease

10.1016/j.isci.2022.104981 · ExternalCitation · doi-reference

Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type

10.1016/j.jaapos.2008.06.008 · ExternalCitation · doi-reference

Ocular manifestations of cobalamin C type methylmalonic aciduria with homocystinuria

10.1016/j.jaapos.2012.02.019 · ExternalCitation · doi-reference

Polymeric nanoparticulate system: A potential approach for ocular drug delivery

10.1016/j.jconrel.2008.12.018 · ExternalCitation · doi-reference

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

10.1016/j.jconrel.2017.01.012 · ExternalCitation · doi-reference

Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations

10.1016/j.jconrel.2019.05.034 · ExternalCitation · doi-reference

Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review

10.1016/j.jconrel.2020.11.049 · ExternalCitation · doi-reference

Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases

10.1016/j.jconrel.2023.01.018 · ExternalCitation · doi-reference

Intravitreal implants manufactured by supercritical foaming for treating retinal diseases

10.1016/j.jconrel.2023.08.047 · ExternalCitation · doi-reference

Utilizing extracellular vesicles as a drug delivery system in glaucoma and RGC degeneration

10.1016/j.jconrel.2024.06.029 · ExternalCitation · doi-reference

Efficacy evaluation of carboplatin -etoposide Co-loaded PLGA microparticles for subconjunctival chemotherapy in retinoblastoma

10.1016/j.jddst.2024.105333 · ExternalCitation · doi-reference

Effect of bimatoprost sustained-release intracameral implant on intraocular pressure and medication burden in patients with prior glaucoma surgery

10.1016/j.jfo.2023.07.016 · ExternalCitation · doi-reference

Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems

10.1016/j.jsps.2024.102193 · ExternalCitation · doi-reference

Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine

10.1016/j.matdes.2020.108805 · ExternalCitation · doi-reference

Interactions between loaded drugs and surfactant molecules in micellar drug delivery systems: A critical review

10.1016/j.molliq.2023.121906 · ExternalCitation · doi-reference

Biodegradable polyurethane nanocomposites containing dexamethasone for ocular route

10.1016/j.msec.2010.10.019 · ExternalCitation · doi-reference

Cobalamin disorder CblC presenting with hemolytic uremic syndrome and pulmonary hypertension

10.1016/j.nefro.2017.03.019 · ExternalCitation · doi-reference

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

10.1016/j.ophtha.2008.10.018 · ExternalCitation · doi-reference

Long-term Visual Outcome of Methylmalonic Aciduria and Homocystinuria, Cobalamin C Type

10.1016/j.ophtha.2013.08.034 · ExternalCitation · doi-reference

Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency

10.1016/j.ophtha.2015.10.041 · ExternalCitation · doi-reference

Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis

10.1016/j.ophtha.2020.01.006 · ExternalCitation · doi-reference

Combined Methylmalonic Aciduria and Homocystinuria cblC Type of a Taiwanese Infant With c.609G>A and c.567dupT Mutations in the MMACHC Gene

10.1016/j.pedneo.2011.05.006 · ExternalCitation · doi-reference

Microcephaly, an etiopathogenic vision

10.1016/j.pedneo.2021.05.008 · ExternalCitation · doi-reference

Crystallins in the eye: Function and pathology

10.1016/j.preteyeres.2006.10.003 · ExternalCitation · doi-reference

Pharmacokinetic aspects of retinal drug delivery

10.1016/j.preteyeres.2016.12.001 · ExternalCitation · doi-reference

Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma

10.1016/j.preteyeres.2020.100901 · ExternalCitation · doi-reference

Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling

10.1016/j.redox.2019.101322 · ExternalCitation · doi-reference

Studies on the influence of β-cyclodextrin derivatives on the physical stability of famotidine

10.1016/j.saa.2019.04.066 · ExternalCitation · doi-reference

Itraconazole loaded nano-structured lipid carrier for topical ocular delivery: Optimization and evaluation

10.1016/j.sjbs.2021.11.006 · ExternalCitation · doi-reference

The impact of strabismus on psychosocial heath and quality of life: A systematic review

10.1016/j.survophthal.2021.03.005 · ExternalCitation · doi-reference

Extracellular vesicles in dry eye disease and Sjögren’s syndrome: A systematic review on their diagnostic and therapeutic role

10.1016/j.survophthal.2025.01.003 · ExternalCitation · doi-reference

Phase I Study of Intravitreal Injection of Autologous CD34+ Stem Cells from Bone Marrow in Eyes with Vision Loss from Retinitis Pigmentosa

10.1016/j.xops.2024.100589 · ExternalCitation · doi-reference

The Role of Surface Active Agents in Ophthalmic Drug Delivery: A Comprehensive Review

10.1016/j.xphs.2019.01.016 · ExternalCitation · doi-reference

High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria

10.1016/j.ymgme.2009.07.017 · ExternalCitation · doi-reference

Ocular disease in the cobalamin C defect: A review of the literature and a suggested framework for clinical surveillance

10.1016/j.ymgme.2015.01.012 · ExternalCitation · doi-reference

Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria

10.1016/s0022-3476(88)80114-8 · ExternalCitation · doi-reference

Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC)

10.1016/s0022-3476(98)70496-2 · ExternalCitation · doi-reference

Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency

10.1016/s0140-6736(15)00076-8 · ExternalCitation · doi-reference

A Comparison of Retrobulbar versus Sub-Tenon’s Corticosteroid Therapy for Cystoid Macular Edema Refractory to Topical Medications

10.1016/s0161-6420(97)30065-7 · ExternalCitation · doi-reference

Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system

10.1016/s0168-3659(01)00279-6 · ExternalCitation · doi-reference

The clinical picture of early-onset cobalamin C defect (methylmalonic aciduria and homocystinuria)

10.1016/s1751-7222(08)70019-2 · ExternalCitation · doi-reference

Emulsions and microemulsions for ocular drug delivery

10.1016/s1773-2247(11)50010-3 · ExternalCitation · doi-reference

Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds

10.1021/acs.jafc.1c06747 · ExternalCitation · doi-reference

Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis

10.1021/acs.molpharmaceut.6b00488 · ExternalCitation · doi-reference

Itraconazole Nanocrystals on Hydrogel Contact Lenses via Inkjet Printing: Implications for Ophthalmic Drug Delivery

10.1021/acsanm.2c01715 · ExternalCitation · doi-reference

Polymer Micelles: An Example of Self-Assembling Polymers

10.1021/jp980386o · ExternalCitation · doi-reference

Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy

10.1021/nn506599f · ExternalCitation · doi-reference

Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: A 16-year experience

10.1038/gim.2016.214 · ExternalCitation · doi-reference

Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation

10.1038/nbt995 · ExternalCitation · doi-reference

Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type

10.1038/ng1683 · ExternalCitation · doi-reference

A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices

10.1038/nmat4355 · ExternalCitation · doi-reference

Vitamin B12 deficiency

10.1038/nrdp.2017.40 · ExternalCitation · doi-reference

Management of nystagmus in children: A review of the literature and current practice in UK specialist services

10.1038/s41433-019-0741-3 · ExternalCitation · doi-reference

Paediatric hydrocephalus

10.1038/s41572-024-00519-9 · ExternalCitation · doi-reference

Unlocking the potential of exosomes ‘extracellular vesicles’: Drug delivery advancements and therapeutics in ocular diseases

10.1039/d5pm00097a · ExternalCitation · doi-reference

Management of the Metabolic Acidosis of Chronic Kidney Disease

10.1053/j.ackd.2017.06.006 · ExternalCitation · doi-reference

Late-onset thrombocytic microangiopathy caused by cblC disease: Association with a factor H mutation

10.1053/j.ajkd.2004.12.004 · ExternalCitation · doi-reference

Renal Thrombotic Microangiopathy: A Review

10.1053/j.ajkd.2022.10.014 · ExternalCitation · doi-reference

Homocystinuria and Megaloblastic Anemia Responsive to Vitamin B12 Therapy: An Inborn Error of Metabolism Due to a Defect in Cobalamin Metabolism

10.1056/nejm198403153101104 · ExternalCitation · doi-reference

Ranibizumab for Neovascular Age-Related Macular Degeneration

10.1056/nejmoa054481 · ExternalCitation · doi-reference

The cblD Defect Causes Either Isolated or Combined Deficiency of Methylcobalamin and Adenosylcobalamin Synthesis

10.1074/jbc.m407733200 · ExternalCitation · doi-reference

Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery

10.1080/02713683.2022.2119254 · ExternalCitation · doi-reference

A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir

10.1080/03639045.2017.1414232 · ExternalCitation · doi-reference

Novel cubosome based system for ocular delivery of acetazolamide

10.1080/10717544.2021.1989090 · ExternalCitation · doi-reference

Polymeric micelles: Authoritative aspects for drug delivery

10.1080/1385772x.2012.688328 · ExternalCitation · doi-reference

Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection

10.1080/17425247.2021.1872542 · ExternalCitation · doi-reference

Recent advances in nanocrystal-based technologies applied for ocular drug delivery

10.1080/17425247.2024.2311119 · ExternalCitation · doi-reference

Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes

10.1089/jop.2022.0144 · ExternalCitation · doi-reference

Neurodevelopmental and Neuropsychiatric Disorders in Cobalamin C Disease: A Case Report and Review of the Literature

10.1101/mcs.a006179 · ExternalCitation · doi-reference

Optical coherence tomography morphology and evolution in cblC disease-related maculopathy in a case series of very young patients

10.1111/aos.13441 · ExternalCitation · doi-reference

Haemolytic uraemic syndrome

10.1111/joim.12546 · ExternalCitation · doi-reference

An annular corneal microneedle patch for minimally invasive ophthalmic drug delivery

10.1126/sciadv.adv1661 · ExternalCitation · doi-reference

Homocystinuria diagnosis and management: It is not all classical

10.1136/jcp-2021-208029 · ExternalCitation · doi-reference

The adolescent and adult form of cobalamin C disease: Clinical and molecular spectrum

10.1136/jnnp.2007.133025 · ExternalCitation · doi-reference

Ophthalmic Drug Dosage Forms: Characterisation and Research Methods

10.1155/2014/861904 · ExternalCitation · doi-reference

Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease

10.1155/2018/4691417 · ExternalCitation · doi-reference

Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac

10.1155/2018/5260976 · ExternalCitation · doi-reference

Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss

10.1167/iovs.15-17857 · ExternalCitation · doi-reference

A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration

10.1167/tvst.10.14.23 · ExternalCitation · doi-reference

Folate and Vitamin B 12 Metabolism: Overview and Interaction with Riboflavin, Vitamin B 6, and Polymorphisms

10.1177/15648265080292s103 · ExternalCitation · doi-reference

Elevated levels of homocysteine compromise blood-brain barrier integrity in mice

10.1182/blood-2005-06-2506 · ExternalCitation · doi-reference

Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol

10.1186/1556-276x-6-275 · ExternalCitation · doi-reference

Retinitis pigmentosa

10.1186/1750-1172-1-40 · ExternalCitation · doi-reference

10.1186/s12881-015-0196-8

10.1186/s12881-015-0196-8 · ExternalCitation · doi-reference

10.1186/s12887-020-02130-9

10.1186/s12887-020-02130-9 · ExternalCitation · doi-reference

Parenteral systems for statin delivery: A review

10.1186/s12944-019-1139-8 · ExternalCitation · doi-reference

Distinct clinical, neuroimaging and genetic profiles of late-onset cobalamin C defects (cb1C): A report of 16 Chinese cases

10.1186/s13023-019-1058-9 · ExternalCitation · doi-reference

Value of amniotic fluid homocysteine assay in prenatal diagnosis of combined methylmalonic acidemia and homocystinuria, cobalamin C type

10.1186/s13023-021-01762-z · ExternalCitation · doi-reference

Adult-onset CblC deficiency: A challenging diagnosis involving different adult clinical specialists

10.1186/s13023-022-02179-y · ExternalCitation · doi-reference

Clinical and genetic analysis of methylmalonic aciduria in 60 patients from Southern China: A single center retrospective study

10.1186/s13023-024-03210-0 · ExternalCitation · doi-reference

Hydrocephalus: Historical analysis and considerations for treatment

10.1186/s40001-022-00798-6 · ExternalCitation · doi-reference

Preparation and ocular pharmacokinetics of ganciclovir liposomes

10.1208/aapsj0903044 · ExternalCitation · doi-reference

Ocular Drug Delivery

10.1208/s12248-010-9183-3 · ExternalCitation · doi-reference

Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery

10.1208/s12249-008-9105-1 · ExternalCitation · doi-reference

Ciprofloxacin as Ocular Liposomal Hydrogel

10.1208/s12249-009-9373-4 · ExternalCitation · doi-reference

In Situ Gelling Gelrite/Alginate Formulations as Vehicles for Ophthalmic Drug Delivery

10.1208/s12249-010-9413-0 · ExternalCitation · doi-reference

Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-inflammatory Activity

10.1208/s12249-018-1166-1 · ExternalCitation · doi-reference

Ocular Drug Delivery: A Comprehensive Review

10.1208/s12249-023-02516-9 · ExternalCitation · doi-reference

Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration

10.1211/jpp.57.12.0005 · ExternalCitation · doi-reference

Cyclodextrins in drug delivery

10.1517/17425247.2.1.335 · ExternalCitation · doi-reference

Applications of poloxamers in ophthalmic pharmaceutical formulations: An overview

10.1517/17425247.2013.796360 · ExternalCitation · doi-reference

Advances in ocular drug delivery: Emphasis on the posterior segment

10.1517/17425247.2014.935338 · ExternalCitation · doi-reference

Ocular drug delivery

10.1517/17425247.3.2.275 · ExternalCitation · doi-reference

Hydrogels for ocular drug delivery and tissue engineering

10.15171/bi.2015.31 · ExternalCitation · doi-reference

Three Main Causes of Homocystinuria: CBS, cblC and MTHFR Deficiency. What do they Have in Common?

10.1590/2326-4594-jiems-2019-0007 · ExternalCitation · doi-reference

10.21203/rs.3.rs-4619093/v1

10.21203/rs.3.rs-4619093/v1 · ExternalCitation · doi-reference

Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases

10.2147/ijn.s532074 · ExternalCitation · doi-reference

Selection Criteria for Oils, Surfactants, and Co-Surfactants in Ocular Nanoemulsion Formulation: A Mini Review

10.2174/0113816128350573241202105210 · ExternalCitation · doi-reference

Role of Cyclodextrins in Ophthalmics

10.2174/1567201043334623 · ExternalCitation · doi-reference

Cubosomes as Targeted Drug Delivery Systems—A Biopharmaceutical Approach

10.2174/1570163811666140505125923 · ExternalCitation · doi-reference

An Overview on Various Approaches and Recent Patents on Gastroretentive Drug Delivery Systems

10.2174/1872211312666180308150218 · ExternalCitation · doi-reference

Aqueous Humor Dynamics: A Review

10.2174/1874364101004010052 · ExternalCitation · doi-reference

Formulation and Evaluation of Moxifloxacin Hydrochloride Loaded Cubosomal Gel for Ocular Delivery

10.22270/jddt.v14i3.6464 · ExternalCitation · doi-reference

10.2903/j.efsa.2015.4150

10.2903/j.efsa.2015.4150 · ExternalCitation · doi-reference

Ocular drug delivery systems: A comprehensive review of innovative formulations, challenges and opportunities

10.30574/gscbps.2024.29.2.0421 · ExternalCitation · doi-reference

Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: Where do we stand?

10.3109/10717544.2014.936535 · ExternalCitation · doi-reference

Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull’s Eye Maculopathy

10.3109/13816810.2015.1010736 · ExternalCitation · doi-reference

Elevated plasma homocysteine levels: Risk factor or risk marker for the development of dementia and Alzheimer’s disease?

10.3233/jad-2006-9404 · ExternalCitation · doi-reference

10.3389/fbioe.2020.00228

10.3389/fbioe.2020.00228 · ExternalCitation · doi-reference

10.3389/fopht.2023.1233866

10.3389/fopht.2023.1233866 · ExternalCitation · doi-reference

10.3389/fped.2022.810495

10.3389/fped.2022.810495 · ExternalCitation · doi-reference

10.3389/fphar.2022.838168

10.3389/fphar.2022.838168 · ExternalCitation · doi-reference

10.3389/fphar.2022.903519

10.3389/fphar.2022.903519 · ExternalCitation · doi-reference

10.3390/biomedicines9091203

10.3390/biomedicines9091203 · ExternalCitation · doi-reference

10.3390/cells12040642

10.3390/cells12040642 · ExternalCitation · doi-reference

10.3390/colloids7010016

10.3390/colloids7010016 · ExternalCitation · doi-reference

10.3390/cryst12040468

10.3390/cryst12040468 · ExternalCitation · doi-reference

10.3390/gels3030025

10.3390/gels3030025 · ExternalCitation · doi-reference

10.3390/gels7040182

10.3390/gels7040182 · ExternalCitation · doi-reference

10.3390/gels8030167

10.3390/gels8030167 · ExternalCitation · doi-reference

10.3390/ijms20225534

10.3390/ijms20225534 · ExternalCitation · doi-reference

10.3390/ma17010086

10.3390/ma17010086 · ExternalCitation · doi-reference

10.3390/nano10050847

10.3390/nano10050847 · ExternalCitation · doi-reference

10.3390/nano10061191

10.3390/nano10061191 · ExternalCitation · doi-reference

10.3390/nano7060122

10.3390/nano7060122 · ExternalCitation · doi-reference

Vitamin B12 in Health and Disease

10.3390/nu2030299 · ExternalCitation · doi-reference

10.3390/ph14010068

10.3390/ph14010068 · ExternalCitation · doi-reference

10.3390/ph15030371

10.3390/ph15030371 · ExternalCitation · doi-reference

10.3390/ph17040511

10.3390/ph17040511 · ExternalCitation · doi-reference

10.3390/pharmaceutics10010010

10.3390/pharmaceutics10010010 · ExternalCitation · doi-reference

10.3390/pharmaceutics11070321

10.3390/pharmaceutics11070321 · ExternalCitation · doi-reference

10.3390/pharmaceutics12030253

10.3390/pharmaceutics12030253 · ExternalCitation · doi-reference

10.3390/pharmaceutics12030269

10.3390/pharmaceutics12030269 · ExternalCitation · doi-reference

10.3390/pharmaceutics13040523

10.3390/pharmaceutics13040523 · ExternalCitation · doi-reference

10.3390/pharmaceutics13071013

10.3390/pharmaceutics13071013 · ExternalCitation · doi-reference

10.3390/pharmaceutics14010134

10.3390/pharmaceutics14010134 · ExternalCitation · doi-reference

10.3390/pharmaceutics15030951

10.3390/pharmaceutics15030951 · ExternalCitation · doi-reference

10.3390/pharmaceutics16081092

10.3390/pharmaceutics16081092 · ExternalCitation · doi-reference

10.3390/polym14091635

10.3390/polym14091635 · ExternalCitation · doi-reference

10.3390/polym14091836

10.3390/polym14091836 · ExternalCitation · doi-reference

10.3390/polym16162240

10.3390/polym16162240 · ExternalCitation · doi-reference

10.3390/scipharm87030015

10.3390/scipharm87030015 · ExternalCitation · doi-reference

Biological properties of extracellular vesicles and their physiological functions

10.3402/jev.v4.27066 · ExternalCitation · doi-reference

Applying extracellular vesicles based therapeutics in clinical trials—An ISEV position paper

10.3402/jev.v4.30087 · ExternalCitation · doi-reference

Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report

10.3892/etm.2017.4970 · ExternalCitation · doi-reference

Severe megaloblastic anemia: Vitamin deficiency and other causes

10.3949/ccjm.87a.19072 · ExternalCitation · doi-reference

Manic-depressive Psychosis as the Initial Symptom in Adult Siblings with Late-onset Combined Methylmalonic Aciduria and Homocystinemia, Cobalamin C Type

10.4103/0366-6999.199826 · ExternalCitation · doi-reference

Nanotechnology approaches for ocular drug delivery

10.4103/0974-9233.106384 · ExternalCitation · doi-reference

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages

10.4103/1735-5362.235156 · ExternalCitation · doi-reference

Homocystinuria: A rare condition presenting as stroke and megaloblastic anemia

10.4103/1817-1745.76110 · ExternalCitation · doi-reference

Homocystinuria and ocular complications–A review

10.4103/ijo.ijo_309_22 · ExternalCitation · doi-reference

Challenges and Opportunities in dermal/transdermal Delivery

10.4155/tde.10.16 · ExternalCitation · doi-reference

Nanoemulsions as Ophthalmic Drug Delivery Systems

10.4274/tjps.galenos.2020.59319 · ExternalCitation · doi-reference

Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: Case report of a patient treated with endothelin receptor antagonist

10.5414/cn106829 · ExternalCitation · doi-reference

Methylmalonic acidemia: Current status and research priorities

10.5582/irdr.2018.01026 · ExternalCitation · doi-reference

Ocular emulsions and dry eye: A case study of a non-biological complex drug product delivered to a complex organ to treat a complex disease

10.5639/gabij.2017.0601.004 · ExternalCitation · doi-reference